José Ignacio
Herrero Santos
Consultor Médico
Centro de Investigación Médica Aplicada
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Médica Aplicada (10)
2023
-
Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, Vol. 29, Núm. 10, pp. 1100-1108
2019
-
Immunophenotypic Pattern of De Novo Malignancy After Liver Transplantation
Transplantation Proceedings, Vol. 51, Núm. 1, pp. 77-79
2017
-
NatB-mediated protein N-α-terminal acetylation is a potential therapeutic target in hepatocellular carcinoma
Oncotarget, Vol. 8, Núm. 25, pp. 40967-40981
-
Phase 1–2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow–derived endothelial progenitor cells
Translational Research, Vol. 188, pp. 80-91.e2
2015
-
Immune monitoring of immunosuppression withdrawal of liver transplant recipients
Transplant Immunology, Vol. 33, Núm. 2, pp. 110-116
2013
-
Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance
Liver Transplantation, Vol. 19, Núm. 9, pp. 937-944
-
Zolmitriptan: A Novel Portal Hypotensive Agent Which Synergizes with Propranolol in Lowering Portal Pressure
PLoS ONE, Vol. 8, Núm. 1
2011
-
Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection
Journal of Hepatology, Vol. 54, Núm. 3, pp. 422-431
-
Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages
Annals of Surgical Oncology, Vol. 18, Núm. 7, pp. 1964-1971
-
Treatment of murine fulminant hepatitis with genetically engineered endothelial progenitor cells
Journal of Hepatology, Vol. 55, Núm. 4, pp. 828-837